Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Thermo Fisher, Population Genetics, Roche, Intelligent Bio-Systems, Others Win US Patents


Boehringer Ingelheim has been awarded US Patent No. 8,741,136, "Device and method for treating or cleaning sample material, in particular nucleic acids."

Ralf-Peter Peters and Holger Bartos are named as inventors.

Life Technologies (Thermo Fisher Scientific) has been awarded US Patent No. 8,741,560, "Stable compositions for nucleic acid amplification and sequencing."

Ayoub Rashtchian and Joseph Solus are named as inventors.

US Patent No. 8,742,114, "Nucleic acid detections and methods of their use," has been awarded to an unspecified assignee.

Laiqiang Ying is named as the inventor, and is an employee at Life Technologies.

Applied Biosystems (Thermo Fisher Scientific) has been awarded US Patent No. 8,741,569, "Methods for normalizing and for identifying small nucleic acids."

Kai Lao, Neil Straus, and John Burns are named as inventors.

Ludwig-Maximilians-Universitat Munchen has been awarded US Patent No. 8,741,570, "Thermo-optical characterization of nucleic acid molecules."

Stefan Duhr and Philipp Baaske are named as inventors.

Population Genetics has been awarded US Patent No. 8,741,606, "Method of tagging using a split DBR."

James Casbon, Sydney Brenner, Robert Osborne, Conrad Lichtenstein, and Andreas Claas are named as inventors.

Roche has been awarded US Patent No. 8,741,617, "DNA polymerases with increased 3'-mismatch discrimination."

Fred Reichert, Keith Bauer, and Thomas Myers are named as inventors.

Roche was also awarded US Patent No. 8,744,777, "Method for real-time quantification of nucleic acids."

Gregor Sagner, Karim Tabiti, Martin Gutekunst, and Richie Soong are named as inventors.

Intelligent Bio Systems has been awarded US Patent Nos. 8,741,815, "Methods and devices for amplification of nucleic acid."

Steven Gordon and Daniel Stetson are named as inventors.

The Trustees of Boston University have been awarded US Patent No. 8,742,084, "Bioreactive agents."

Kenneth Rothschild, Sanjay Sonar, and Jerzy Olejnik are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.